NextTrip Inc (NTRP)
NASDAQ
Synthetic Bryostatin Available to Expand Neurodegenerative Indication Trials PR Newswire NEW YORK, Feb. 4, 2021 NEW YORK, Feb. 4, 2021 /PRNewswire/ -- Synaptogenix, Inc. (OTC: SNPX) announced...
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals - Petros to Grow and Pursue Non-Prescription / Over-The-Counter ("OTC") Strategies...
Neurotrope, Inc. Approves Spin-Off of Neurotrope Bioscience, Inc. and Sets Record and Distribution Dates Spin-Off Distribution is Conditional Upon the Closing of Neurotrope's Proposed Merger with...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.06 | 2.11267605634 | 2.84 | 3.33 | 2.8 | 4611 | 2.91802091 | CS |
4 | 0.44 | 17.8861788618 | 2.46 | 3.81 | 2.09 | 8535 | 2.88682146 | CS |
12 | 1.02 | 54.2553191489 | 1.88 | 4.4 | 1.86 | 12027 | 2.91812132 | CS |
26 | -1.52 | -34.3891402715 | 4.42 | 4.7775 | 1.475 | 10891 | 2.88955781 | CS |
52 | 1.959 | 208.182784272 | 0.941 | 6.8097 | 0.941 | 10235 | 3.84149875 | CS |
156 | 1.959 | 208.182784272 | 0.941 | 6.8097 | 0.941 | 3394 | 3.84149875 | CS |
260 | 2.06 | 245.238095238 | 0.84 | 6.8097 | 0.59 | 133805 | 1.22571072 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.